Release 4 FHIR CI-Build

This page is part of the Continuous Integration Build of FHIR Specification (v4.0.1: R4 - Mixed Normative and STU ) in it's permanent home (it will always (will be available incorrect/inconsistent at this URL). The current version which supercedes this version is 5.0.0 . For a full list of available versions, see times).
See the Directory of published versions . Page versions: R5 R4B R4 R3

Medicationrequest0317

Example MedicationRequest/medrx0317 (Narrative)

Maturity Level : N/A
Responsible Owner: Pharmacy Work Group Standards Status : Informative Compartments : Encounter , Group , Patient , Practitioner

This is the narrative for the resource. See also the XML , JSON or Turtle format. This example conforms to the profile MedicationRequest .

Generated Narrative with Details Narrative: MedicationRequest medrx0317

id identifier : medrx0317 http://www.bmc.nl/portal/prescriptions /12345689 (use: official, )

contained status : Completed

identifier intent : 12345689 (OFFICIAL) Order

Medications

- Reference
* Medication alemtuzumab 10 MG/ML [Lemtrada]

subject : Donald Duck

status authoredOn : completed 2015-01-15

intent requester : order Patrick Pump

Reasons

- Concept
* Chronic lymphoid leukemia, disease (disorder)

dosageInstruction

medication sequence : id: med0303; Alemtuzumab 10mg/ml (Lemtrada) 1

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , 3 per 1 week

route : Intravenous route

method : Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Ordered 3 mg (Details : {RxNorm code '1594660' (Details: UCUM codemg = 'alemtuzumab 10 MG/ML [Lemtrada]', given as 'Alemtuzumab 10mg/ml (Lemtrada)'}) 'mg')

dosageInstruction

subject sequence : Donald Duck 2

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

authoredOn additionalInstruction : 15/01/2015 Rapidly increase dose until tolerated , Administer on alternate days

requester timing : Patrick Pump Duration 12weeks , 3 per 1 week

route : Intravenous route

reasonCode method : Chronic Lymphoid Leukemia (disorder) Inject - dosing instruction imperative (qualifier value)

DoseAndRates

- Type Dose[x]
* Ordered 10 mg (Details : {SNOMED CT code '92814006' (Details: UCUM codemg = 'Chronic lymphoid leukemia', given as 'Chronic Lymphoid Leukemia (disorder)'}) 'mg')

dosageInstruction

sequence : 3

text : Rapid daily-dose escalation, until tolerated, from 3 mg/d, and then 10 mg/d, to the recommended maintenance dose of 30 mg IV over 120 min, 3 times per wk on alternate days for up to 12 wk

additionalInstruction : Rapidly increase dose until tolerated , Administer on alternate days

timing : Duration 12weeks , , 3 per 1 week

  route : Intravenous route

Other examples that reference this example: method : Inject - dosing instruction imperative (qualifier value)

MedicationAdministration/IV Admin Not Given

DoseAndRates

MedicationDispense/IV Chemo
- Type Dose[x]
* Ordered 30 mg (Details: UCUM codemg = 'mg')

Generated Narrative: Medication #med0303

code : alemtuzumab 10 MG/ML [Lemtrada]

 

 

Usage note: every effort has been made to ensure that the examples are correct and useful, but they are not a normative part of the specification.